SANUWAVE Health (SNWV) Research & Development (2010 - 2026)

SANUWAVE Health (SNWV) has reported Research & Development for 17 consecutive years, with $1.9 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Research & Development rose 14.87% year-over-year to $1.9 million in Q2 2026; TTM through Jun 2026 was $8.5 million, a 17.54% increase from a year earlier, with the FY2025 full-year figure at $7.4 million, up 17.33% from the prior year.
• Research & Development was $1.9 million for Q2 2026 at SANUWAVE Health, down from $2.4 million in the prior quarter.
• Over five years, Research & Development peaked at $2.4 million in Q4 2022 and troughed at $978000.0 in Q2 2023.
• A 5-year average of $1.7 million and a median of $1.7 million in 2022 frame the typical range for Research & Development.
• Across the five-year window, Research & Development sank 41.51% in 2023 and soared 111.93% in 2024, its largest moves.
• Over 5 years, Research & Development stood at $2.4 million in 2022, then tumbled by 39.76% to $1.5 million in 2023, then advanced by 26.36% to $1.9 million in 2024, then increased by 14.99% to $2.1 million in 2025, then declined by 9.85% to $1.9 million in 2026.
• The last three Research & Development figures came in at $1.9 million (Q2 2026), $2.4 million (Q1 2026), and $2.1 million (Q4 2025), per Business Quant data.